Harnessing serotonergic and dopaminergic pathways for lymphoma therapy: evidence and aspirations.

@article{Barnes2008HarnessingSA,
  title={Harnessing serotonergic and dopaminergic pathways for lymphoma therapy: evidence and aspirations.},
  author={Nicholas M. Barnes and John Gordon},
  journal={Seminars in cancer biology},
  year={2008},
  volume={18 3},
  pages={218-25}
}
Growing evidence supports the notion that pharmaceutical targeting of the 5-hydroxytryptamine (5-HT) and dopamine (DA) systems offers the potential to treat human immune system disorders. This review describes this emerging area of research, which has the benefit of being supported by a relatively detailed understanding of these monoamine systems within other tissues of the body. Furthermore, the availability of a number of pharmaceutical agents originally developed to manipulate central… CONTINUE READING
Recent Discussions
This paper has been referenced on Twitter 1 time over the past 90 days. VIEW TWEETS

From This Paper

Topics from this paper.

Similar Papers

Loading similar papers…